ascopubs.org9d
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study
The phase III JBCRG-M06/EMERALD study, whose results accompany this editorial, 16 pursued a head-to-head comparison of eribulin versus taxanes for first-line, HER2-positive locally advanced or MBC. A ...
ascopubs.org9d
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study The following represents disclosure information ...